Posts by: Iqra Mumal, MSc

Iqra Mumal, MSc

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

February 20, 2020February 20, 2020

Dental Care Crucial to Children with PWS Due to Inadequate and Acidic Saliva, Study Says

News

Children with Prader-Willi syndrome (PWS) secrete less saliva and more acidic saliva than do their healthy peers. These changes put them at a higher risk of tooth decay (caries) and ... Read more

February 18, 2020February 18, 2020

Psychiatric Symptoms More Common in PWS than in Other Genetic Diseases, Study Finds

News

Children and young adults with Prader-Willi syndrome (PWS) have a higher prevalence of psychiatric symptoms than their peers with other genetic disorders associated with intellectual disability (ID), a study shows. ... Read more

February 13, 2020February 13, 2020

Tiny DNA Deletion Including SNORD116 Gene Causes PWS-Like Disease, Case Study Shows

News

Loss of a region on chromosome 15 that involves the SNORD116 gene leads to the development of Prader-Willi syndrome (PWS)-like disease, suggesting that missing the gene is enough to cause ... Read more

January 9, 2020January 9, 2020

ZEPHYR Trial Testing Livoletide for Hyperphagia Still Recruiting Children Ages 4-7

News

Livoletide, a potential therapy to curb excessive eating among people with Prader-Willi syndrome (PWS), is being tested in a global Phase 2b/3 clinical trial called ZEPHYR. Although recruitment of participants ... Read more

November 19, 2019November 19, 2019

FDA Grants Fast Track Designation to PWS Potential Therapy LV-101

News

The U.S. Food and Drug Administration (FDA) has granted fast track designation to LV-101 (intranasal carbetocin), a treatment candidate for people with Prader-Willi syndrome (PWS). This designation is granted to ... Read more

November 12, 2019November 12, 2019

Obesity and Bone Fractures in Children with PWS Tied to High Blood Levels of Protein, Study Says

News

Children with Prader-Willi syndrome (PWS) have high levels of a protein called LIGHT/TNFSF14, which may contribute to obesity and low bone mineral density (BMD), a study suggests. The research, “High ... Read more

November 7, 2019November 7, 2019

Daily Probiotic Reduces Abdominal Fat and Insulin Resistance in Children with PWS, Study Finds

News

Daily consumption of a common probiotic significantly lowered the percentage of abdominal fat, improved insulin resistance, and reduced social withdrawal in patients with Prader-Willi syndrome, a study has found. The ... Read more

October 31, 2019October 31, 2019

Home-based Exercise Improves Physical Activity in Women with PWS, Study Determines

News

Supervised exercise sessions at home are an effective strategy to improve the levels of physical activity and walking capacity among women with Prader-Willi syndrome (PWS), a new study suggests. The ... Read more

February 14, 2019February 14, 2019

Bariatric Surgery a Feasible Option for Adolescents with Prader-Willi, Case Report Suggests

News

With careful multidisciplinary evaluation and psychosocial support, adolescents with Prader-Willi syndrome (PWS) with severe obesity can undergo bariatric surgery with successful results, a case report suggests. The study, “Laparoscopic sleeve gastrectomy ... Read more

August 20, 2018August 20, 2018

Surgery Can Successfully Treat Obstructive Sleep Apnea, Malocclusion in PWS, Case Study Reports

News

Patients with Prader-Willi syndrome (PWS) who develop significant obstructive sleep apnea and malocclusion can be successfully treated using surgical methods, according to a case report. The case study, “Orthognathic Correction ... Read more